• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Long-Term Symptoms among COVID-19 Survivors in Prospective Cohort Study, Brazil

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2022 Feb 8;28(3).
doi: 10.3201/eid2803.212020. Online ahead of print.
Long-Term Symptoms among COVID-19 Survivors in Prospective Cohort Study, Brazil

Lívia P Bonifácio, Viviane N F Csizmar, Francisco Barbosa-Júnior, Ana P S Pereira, Marcel Koenigkam-Santos, Danilo T Wada, Gilberto G Gaspar, Felipe S Carvalho, Valdes R Bollela, Rodrigo C Santana, João P Souza, Fernando Bellissimo-Rodrigues

Abstract

We conducted a prospective cohort study in a population with diverse ethnic backgrounds from Brazil to assess clinically meaningful symptoms after surviving coronavirus disease. For most of the 175 patients in the study, clinically meaningful symptoms, including fatigue, dyspnea, cough, headache, and muscle weakness, persisted for >120 days after disease onset.

Keywords: Brazil; COVID-19; SARS-CoV-2; cohort; coronavirus disease; long COVID; post-COVID condition; post-acute COVID-19 syndrome; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
 
Back
Top Bottom